3-Bromo-4-(difluoromethyl)benzoic acid, 95.0%, 10g

N-methoxy-N,4-dimethylpentanamide, 95.0%, 2g

Methyl 2,4-difluorobenzoate, 98.0%, 100g

((4-Iodophenyl)ethynyl)trimethylsilane, 95.0%, 5g

2-Chloro-6-methyl-4-nitropyridine, 97%, 10g

3-carboethoxyphenyl cyclobutyl ketone, 97.0%, 1g

3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one, 95.0%, 10mg

4-[4-(1-piperidinyl)butoxy]benzaldehyde hydrochloride, 95.0%, 5g

Vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy terminated cSt 250-350, 100g

2-Amino-5-(2,2,2-trifluoroethyl)thiophene-3-carboxamide, 98%, 500mg

1-BOC-3-ALLYLAZETIDINE, 95.0%, 5g

6-(2-Chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole, 95.0%, 5g

3-Bromobicyclo[4.2.0]octa-1,3,5-triene>98.0%(GC)200mg